4-HNE |
4-hydroxy-2,3-nonenal |
ABVD |
Adriamycin, Bleomycin, Vincristine and Dexamethasone |
ACR |
Acrolein |
AGEs |
Advanced glycation end-products |
ALEs |
Advanced lipid peroxidation end-products |
ALL |
Acute lymphoblastic leukemia |
AML |
Acute myeloid leukemia |
AOPPs |
Advanced oxidation protein products |
APL |
Acute promyelocytic leukemia |
B CLL |
B-cell chronic lymphoblastic leukemia |
BM |
Bone marrow |
CAT |
Catalase |
CHOP |
Cyclophosphamide, Vincristine, Doxorubicin, and Prednisone |
CML |
Chronic myeloid leukemia |
COX |
Cyclooxygenase |
DFX |
Deferasirox |
DLBCL |
Diffuse large B-cell lymphoma |
DNP |
Dinitrophenylhydrazone |
DNPH |
Dinitrophenylhydrazine |
DOX-TRF |
Doxorubicin-transferrin |
ET |
Essential thrombocythemia |
GO |
Glyoxal |
GPX |
Glutathione peroxidase |
HL |
Hodgkin lymphoma |
IOL |
Iron overload |
LO |
Lipoxygenase |
MAD |
Malondialdehyde |
MGO |
Methyglyoxal |
MGUS |
Monoclonal gammapathy of undetermined significance |
MM |
Multiple myeloma |
MPN |
Myeloproliferative neoplasms |
NANA |
N-acetyl neuraminic acid |
NHL |
Non-Hodgkin lymphoma |
NOS |
Nitric oxide synthase |
ns |
Nonsignificant |
ONE |
4-oxo-2-nonenal |
PC |
Protein carbonylation |
PMF |
Primary myelofibrosis |
PN |
Protein nitrosylated |
PUFA |
Polyunsaturated fatty acyl |
PV |
Polycythemia vera |
ROS |
Reactive oxygen species |
SOD |
Superoxide dismutase |
TBARS |
Thiobarbituric reactive substances |
Trx |
Thioredoxin |
VAD |
Vincristine–Adriamycin–Dexamethasone |